| 285 Updating the evidence for the IPDAS standards: results from a network meta-analysis RJ Volk, D Stacey, KB Lewis, M Smith, M Carley, J Gunderson, SC Hseih, ... BMJ Evidence-Based Medicine 29 (Suppl 1), A135-A135, 2024 | | 2024 |
| A scoping review shows that no single existing risk of bias assessment tool considers all sources of bias for cross-sectional studies SE Kelly, SPJ Brooks, K Benkhedda, AJ MacFarlane, ... Journal of Clinical Epidemiology, 111408, 2024 | | 2024 |
| A Screening Approach Combining Crowd-Sourcing and Automation Facilitated the Identification and Classification of Randomized Controlled Trials in a Living Systematic Review MM Kamso, JP Pardo, S Whittle, R Buchbinder, G Wells, V Glennon, ... Available at SSRN 4555180, 0 | | |
| A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism … A Johnston, SC Hsieh, M Carrier, SE Kelly, Z Bai, B Skidmore, GA Wells PloS one 13 (11), e0207410, 2018 | 40 | 2018 |
| Additive toxicity arising from combined use of immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with renal or endometrial carcinoma: Protocol for a rapid … SE Kelly, X Wang, SC Hsieh, A Abdul-Wahid, M Derry, B Skidmore, ... MethodsX 12, 102730, 2024 | | 2024 |
| Additive Toxicity From Combined Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors in Patients with Renal or Endometrial Carcinoma: Protocol for a Rapid Systematic Review SE Kelly, X Wang, S Hsieh, A Abdul-Wahid, M Derry, B Skidmore, G Wells Available at SSRN 4711437, 0 | | |
| ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis J Elliott, Z Bai, SC Hsieh, SE Kelly, L Chen, B Skidmore, S Yousef, ... PLOS ONE 15 (2), e0229179, 2020 | 76 | 2020 |
| Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma GA Wells, J Elliott, S Kelly, A Johnston, B Skidmore, J Kofsky ODPRN: Ontario Drug Policy Research Network, 2015 | | 2015 |
| Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma: an umbrella review J Elliott, SE Kelly, A Johnston, B Skidmore, T Gomes, GA Wells Canadian Medical Association Open Access Journal 5 (2), E373-E385, 2017 | 34 | 2017 |
| An evaluation of DistillerSR’s machine learning-based prioritization tool for title/abstract screening–impact on reviewer-relevant outcomes C Hamel, SE Kelly, K Thavorn, DB Rice, GA Wells, B Hutton BMC Medical Research Methodology 20, 1-14, 2020 | 76 | 2020 |
| Antimicrobial resistance: global report on surveillance World Health Organization World Health Organization, 2014 | 6969 | 2014 |
| Atypical antipsychotics for the behavioural and psychological symptoms of dementia in the elderly GA Wells, S Kelly, A Johnston, A Bai, L Chen, A Kotb, B Skidmore | | 2015 |
| BASE-CASE ANALYSIS ADDITIONAL RESULTS G Murphy, B Farah, W Wong, M Krahn, G Wells, L Chen, S Kelly, ... Direct-Acting Antiviral Agents for Chronic Hepatitis C Genotype 1 [Internet], 2014 | | 2014 |
| Benefits From Incorporating Network Meta-Analysis Within Stratified Cost-Effectiveness Analysis D Coyle, K Coyle, C Cameron, KM Lee, S Kelly, S Steiner, G Wells Value in Health 17 (3), A3, 2014 | 1 | 2014 |
| Bisphosphonates for postmenopausal osteoporosis: a network meta‐analysis Cochrane Musculoskeletal Group, SC Hsieh, T Kibret, JS Hamid, SE Kelly, ... Cochrane Database of Systematic Reviews 2023 (9), 1996 | | 1996 |
| CLINICAL REVIEW G Wells, D Coyle, C Cameron, S Steiner, K Coyle, S Kelly, A Tang, ... Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants …, 2012 | | 2012 |
| Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy: A systematic review and … H Zheng, RJ Sigal, D Coyle, Z Bai, A Johnston, J Elliott, S Hsieh, SE Kelly, ... Diabetes/Metabolism Research and Reviews 38 (4), e3515, 2022 | 7 | 2022 |
| Comparative safety and effectiveness of inhaled long-acting agents (corticosteroids, beta agonists, anticholinergics) for chronic obstructive pulmonary S Kelly, G Wells ODPRN: Ontario Drug Policy Research Network, 2014 | | 2014 |
| Comprehensive Research Plan G Wells, S Kelly, L Chen, A Bai, A Johnston, B Skidmore | | 2014 |
| Conclusions and Implications for Decision-or Policy-Making GA Wells, J Elliott, S Kelly, Z Bai, M Boucher, B Skidmore, D So, ... Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention …, 2019 | | 2019 |
George A. WellsUniversity of Ottawa在 ottawaheart.ca 的电子邮件经过验证
